Tuesday, January 13, 2015 12:25:38 AM
June 25 2013 Marsh 7.6 million shares beneficially owned out of 107 million out at the time. 7.3%. He isn't listed as a large shareholder prior to this. This would be around the time you claim his rumor spreading and dumping into it.
March 31 2014 Marsh 8.1 million out of 122 million. The date is 9 full months later .... ownership dropped to 6.6% yet share count went up. Based on YOUR timeline he apparently was putting his money where his mouth was buying the stock and wasn't dumping into this so called rumor spreading summer 2013. The facts dont jive with your argument. Care to explain ?
August 27 2014 Marsh not listed on proxy. Did Marsh sell shares mid 2014 due to a divorce ? I don't know.
By April 2014 the stock is already less than .20 ..... Soooooooo quite frankly Dahl's utter screw up of description of the timing of the deal with ZTS is a huge reason for the stock being hammered around that time.
BTW ..... how many warrants did Marsh own that expired in 2014 ? Marsh known to be investor here for a number of years. To date, a total of 9.8 million warrants are known to have expired during 2014 based on SEC filings. Warrants included in beneficial ownership. Could a shareholder fall below 5% without doing anything ?? Yup.
The SEC filings don't fit your story. Funny ZIVO landed ZTS after summer 2013 too. Marsh owns more shares in early 2014. Hmmmmmm ....... And ZTS still on board after a year of testing. Surely ZTS would know by now if the bioactive didn't do anything. And we've just had some news from ZIVO indicating the bioactive showing positive preliminary results against a target that apparently there is no treatment for ..... tested by ZTS' go to independent CRO Dairy Experts. A study that actually occurred in the field with live dairy cows with the actual infection (that is where the rubber meets the road) .... Not a model in a test tube in a lab.
You label Marsh a POS yet you dont get the facts right. Hmmmmmmm ........ One should probably get the facts right before throwing stones !!!!!
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM